Smokefree Environments and Regulated Products
Submission to Ministry of Health, 24 August 2022
Resources /
Submissions /
-
Submissions
- Advanced Cardiac Life Support Requirements for PGY1 Interns
- Proposal to fund the contraceptive pill desogestrel
- Proposal to widen access to medicines for blood cancer, inflammatory bowel diseases, eczema and rheumatoid arthritis
- Proposal to change the regulatory and funding restrictions for stimulant treatments for ADHD
- Safety measures for the use of puberty blockers
- MedSafe Medical Classifications Committee (MCC) 73rd Meeting
- Treaty Principles Bill submission
- Unlocking the potential of active ageing
- Extension of the provisional vocational assessment period
- Proposal to increase the period of supply limit from 3 to 12 months
- Proposal to fund β-hCG low sensitivity urine test kits
- Hauora Māori Strategy
- Proposal to fund lung treatments, breast cancer, chronic obstructive pulmonary disease (COPD), prevention of RSV
- Agenda of Medicines Classification Committee meeting
- Strategy to Prevent and Minimise Gambling Harm
- Amendments to the Smokefree Environments and Regulated Products Act
- Proposal to remove the renewal criteria for stimulant treatments
- Proposal to fund lisdexamfetamine for ADHD
- Medical aspects of fitness to drive: a guide for health practitioners
- Land Transport (Drug Driving) Amendment Bill
- Proposal to allow pharmacists to provide paracetamol to children under 2 years of age receiving the Bexsero vaccine
- Proposal to enable many childhood vaccinations to be given in pharmacies
- Emergency Management Bill
- Inquiry into Climate Adaptation
- Ministry of Health Precision Health
- Cost of Treatment Regulations
- Women’s Health Strategy
- The Therapeutic Products Bill
- Class B drug legislation
- Smokefree Environments and Regulated Products
- PASE whitepaper: more than a disease-based model
- Diabetes Action Plan 2022-2027
- HDC Case 20HDC00866
Also in this category
Submissions
HDC Case 20HDC00866
Submission to Office of the Health and Disability Commissioner,
View resource
Submissions
Proposal to widen access to medicines for blood cancer, inflammatory bowel diseases, eczema and rheumatoid arthritis
Submission to Pharmac
View resource
Submissions
Proposal to change the regulatory and funding restrictions for stimulant treatments for ADHD
Submission to Pharmac
View resource